Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Biome Australia Ltd ( (AU:BIO) ).
Biome Australia Ltd has issued 2,513,802 fully paid ordinary shares following the exercise of options, expanding its share capital base. The company confirmed that these shares were issued without a prospectus but remain within the legal framework governing capital raising by ASX-listed entities.
By lodging a secondary trading notice, Biome ensured that the new shares can be freely traded under the exemption in section 708A(5) of the Corporations Act. The board also affirmed full compliance with continuous disclosure and financial reporting obligations, signalling no undisclosed information that would materially affect investors’ assessment of the company or the new shares.
The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.38 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Ltd, listed on the ASX under the ticker BIO, operates in the broader healthcare and life sciences sector. While this announcement does not detail its specific products or services, the company is structured as a listed public entity subject to Australia’s continuous disclosure and financial reporting regimes, indicating a focus on regulated capital markets participation.
Average Trading Volume: 257,805
Technical Sentiment Signal: Hold
Current Market Cap: A$81.94M
See more data about BIO stock on TipRanks’ Stock Analysis page.